Abstract
Most antihypertensive drugs prescribed are marketed under the racemic form, despite the well-known fact that the presence of different enantiomers in a pharmaceutical formulation can lead to different pharmacological activities, distinct pharmacokinetic and toxicological profiles. The use of the pure enantiomers in pharmaceutical formulations may result in better dose adjustment and reduc…